In 2002, Carl Zeiss Meditec AG, as it is known today, was created from the merger of the ZEISS Ophthalmology division with Asclepion-Meditec AG, a medical lasers specialist. On 22 July 2002, the Carl Zeiss Meditec AG shares were traded on the Neuer Markt for the first time, making it a publicly traded. Since then, the company has been striving to shape medical progress, efficiency and access to healthcare through innovative technology and support doctors to improve their patients’ quality of life. The Company does this by combining diagnostics technology with therapy and surgical solutions that optimize customers' workflows to more effectively diagnose and treat diseases. And thus, out of a ZEISS division steeped in optical legacy and a nascent start-up within that division emerged to what is now a world leader in ophthalmology and microsurgery: Carl Zeiss Meditec AG.
The following page provides an overview of important milestones in the company's development.